Approximately 2,748,431 patients with T2DM were noted in the US Collaborative Network Database; 6% (n = 167,077) were being treated with a GLP-1 RA, and 94% (n = 2,581,354) were not being treated with a GLP-1 RA. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.